Seda

Seda is a specialized service provider offering end-to-end pharmaceutical development and clinical pharmacology support to the biopharma industry. Its core value proposition lies in applying deep scientific expertise across drug metabolism and pharmacokinetics (DMPK), formulation development, and regulatory strategy to maximize asset value for clients. By integrating consultancy, laboratory, and modelling services, Seda helps clients navigate from preclinical stages through clinical supply, with a focus on optimizing product design and predicting human performance. The company is privately held and operates as a fee-for-service consultancy and contract research organization.

Integrated suite of pharmaceutical development and clinical pharmacology services, including in silico/in vitro predictive modelling, a library of formulation technologies (oral & parenteral), state-of-the-art labs, and deep DMPK expertise.

Seda competes in a crowded market including large, full-service CROs (e.g., IQVIA, Parexel) and numerous niche consulting firms specializing in CMC, formulation, or clinical pharmacology. Its differentiation lies in the integrated application of product design, performance prediction, and clinical supply, offering a seamless, scientifically rigorous service for early-stage assets.